[1]
Tomei, L. 2023. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Italian Journal of Pediatric Allergy and Immunology. 36, 4 (Jan. 2023), 40–41.